IL160380A0 - Inhalation compositions comprising tricyclic 5,6-dihydro-9h- pyrazolo (3,4,-c)-1,2,4-triazolo (4,3-alpha) pyridines - Google Patents
Inhalation compositions comprising tricyclic 5,6-dihydro-9h- pyrazolo (3,4,-c)-1,2,4-triazolo (4,3-alpha) pyridinesInfo
- Publication number
- IL160380A0 IL160380A0 IL16038002A IL16038002A IL160380A0 IL 160380 A0 IL160380 A0 IL 160380A0 IL 16038002 A IL16038002 A IL 16038002A IL 16038002 A IL16038002 A IL 16038002A IL 160380 A0 IL160380 A0 IL 160380A0
- Authority
- IL
- Israel
- Prior art keywords
- triazolo
- pyrazolo
- pyridines
- tricyclic
- dihydro
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 150000003222 pyridines Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M13/00—Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0122031.8A GB0122031D0 (en) | 2001-09-12 | 2001-09-12 | Use of pde4 inhibitors in a dry powder inhaler |
| PCT/IB2002/003599 WO2003022275A1 (en) | 2001-09-12 | 2002-09-02 | Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL160380A0 true IL160380A0 (en) | 2004-07-25 |
Family
ID=9921954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16038002A IL160380A0 (en) | 2001-09-12 | 2002-09-02 | Inhalation compositions comprising tricyclic 5,6-dihydro-9h- pyrazolo (3,4,-c)-1,2,4-triazolo (4,3-alpha) pyridines |
Country Status (34)
| Country | Link |
|---|---|
| US (3) | US20030064031A1 (xx) |
| EP (1) | EP1427414A1 (xx) |
| JP (1) | JP2005505560A (xx) |
| KR (1) | KR20040036940A (xx) |
| CN (1) | CN1553801A (xx) |
| AP (2) | AP2002002623A0 (xx) |
| AR (2) | AR036474A1 (xx) |
| BG (1) | BG108569A (xx) |
| BR (1) | BR0212449A (xx) |
| CA (1) | CA2457717A1 (xx) |
| CZ (1) | CZ2004310A3 (xx) |
| EA (1) | EA006742B1 (xx) |
| EC (1) | ECSP045018A (xx) |
| EE (1) | EE200400078A (xx) |
| GB (1) | GB0122031D0 (xx) |
| HN (2) | HN2002000253A (xx) |
| HR (1) | HRP20040162A2 (xx) |
| HU (1) | HUP0401890A3 (xx) |
| IL (1) | IL160380A0 (xx) |
| IS (1) | IS7151A (xx) |
| MA (1) | MA27062A1 (xx) |
| MX (1) | MXPA04002354A (xx) |
| NO (1) | NO20041011L (xx) |
| NZ (1) | NZ530929A (xx) |
| OA (1) | OA12660A (xx) |
| PA (2) | PA8554601A1 (xx) |
| PE (2) | PE20030509A1 (xx) |
| PL (1) | PL368736A1 (xx) |
| SK (1) | SK1272004A3 (xx) |
| SV (2) | SV2004001227A (xx) |
| TN (1) | TNSN04040A1 (xx) |
| TW (1) | TW200602054A (xx) |
| WO (2) | WO2003022275A1 (xx) |
| ZA (1) | ZA200401002B (xx) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040176391A1 (en) * | 2002-12-31 | 2004-09-09 | Nektar Therapeutics | Aerosolizable pharmaceutical formulation for fungal infection therapy |
| US7931022B2 (en) | 2001-10-19 | 2011-04-26 | Respirks, Inc. | Method and apparatus for dispensing inhalator medicament |
| GB0315889D0 (en) | 2003-07-08 | 2003-08-13 | Aventis Pharma Ltd | Stable pharmaceutical products |
| US20060009435A1 (en) * | 2004-06-23 | 2006-01-12 | Joseph Kaspi | Synthesis and powder preparation of fluticasone propionate |
| WO2007036029A1 (en) * | 2005-09-28 | 2007-04-05 | Merck Frosst Canada Ltd. | Aerosol powder formulation comprising sieved lactose |
| GB0801876D0 (en) * | 2008-02-01 | 2008-03-12 | Vectura Group Plc | Suspension formulations |
| US8834931B2 (en) | 2009-12-25 | 2014-09-16 | Mahmut Bilgic | Dry powder formulation containing tiotropium for inhalation |
| TR200909788A2 (tr) * | 2009-12-25 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu |
| AP2015008663A0 (en) | 2013-02-19 | 2015-08-31 | Pfizer | Azabenzimidazole compounds as inhibitors of PDE4 isozymes for the treatment of cns and other disorders |
| KR20150076005A (ko) | 2013-12-26 | 2015-07-06 | 삼성디스플레이 주식회사 | 액정 표시 장치 |
| JP6713982B2 (ja) | 2014-07-24 | 2020-06-24 | ファイザー・インク | ピラゾロピリミジン化合物 |
| CU20170007A7 (es) | 2014-08-06 | 2017-06-05 | Pfizer | Compuestos de imidazopiridazina |
| CN111249260B (zh) * | 2014-09-15 | 2023-01-10 | 维罗纳制药公司 | 包含rpl554的液体吸入制剂 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6004974A (en) * | 1995-06-06 | 1999-12-21 | Pfizer Inc | Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-α]pyridines |
| US5985309A (en) * | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| DE19835346A1 (de) * | 1998-08-05 | 2000-02-10 | Boehringer Ingelheim Pharma | Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren |
-
2001
- 2001-09-12 GB GBGB0122031.8A patent/GB0122031D0/en not_active Ceased
-
2002
- 2002-09-02 OA OA1200400071A patent/OA12660A/en unknown
- 2002-09-02 WO PCT/IB2002/003599 patent/WO2003022275A1/en not_active Application Discontinuation
- 2002-09-02 IL IL16038002A patent/IL160380A0/xx unknown
- 2002-09-02 JP JP2003526404A patent/JP2005505560A/ja not_active Withdrawn
- 2002-09-02 NZ NZ530929A patent/NZ530929A/en unknown
- 2002-09-02 WO PCT/IB2002/003598 patent/WO2003022279A1/en not_active Application Discontinuation
- 2002-09-02 EA EA200400301A patent/EA006742B1/ru not_active IP Right Cessation
- 2002-09-02 BR BR0212449-1A patent/BR0212449A/pt not_active IP Right Cessation
- 2002-09-02 CA CA002457717A patent/CA2457717A1/en not_active Abandoned
- 2002-09-02 EP EP02767763A patent/EP1427414A1/en not_active Withdrawn
- 2002-09-02 PL PL02368736A patent/PL368736A1/xx not_active Application Discontinuation
- 2002-09-02 HU HU0401890A patent/HUP0401890A3/hu unknown
- 2002-09-02 MX MXPA04002354A patent/MXPA04002354A/es not_active Application Discontinuation
- 2002-09-02 CZ CZ2004310A patent/CZ2004310A3/cs unknown
- 2002-09-02 SK SK127-2004A patent/SK1272004A3/sk not_active Application Discontinuation
- 2002-09-02 KR KR10-2004-7003619A patent/KR20040036940A/ko active IP Right Grant
- 2002-09-02 EE EEP200400078A patent/EE200400078A/xx unknown
- 2002-09-02 CN CNA028178874A patent/CN1553801A/zh active Pending
- 2002-09-05 US US10/236,551 patent/US20030064031A1/en active Pending
- 2002-09-05 US US10/236,228 patent/US20030064034A1/en not_active Abandoned
- 2002-09-10 AR ARP020103427A patent/AR036474A1/es unknown
- 2002-09-10 AR ARP020103426A patent/AR036473A1/es unknown
- 2002-09-10 PE PE2002000893A patent/PE20030509A1/es not_active Application Discontinuation
- 2002-09-10 PE PE2002000894A patent/PE20030443A1/es not_active Application Discontinuation
- 2002-09-11 TW TW094130352A patent/TW200602054A/zh unknown
- 2002-09-11 HN HN2002000253A patent/HN2002000253A/es unknown
- 2002-09-12 PA PA20028554601A patent/PA8554601A1/es unknown
- 2002-09-12 AP APAP/P/2002/002623A patent/AP2002002623A0/en unknown
- 2002-09-12 SV SV2002001227A patent/SV2004001227A/es not_active Application Discontinuation
- 2002-09-12 PA PA20028554701A patent/PA8554701A1/es unknown
- 2002-09-12 AP APAP/P/2002/002624A patent/AP2002002624A0/en unknown
- 2002-09-12 SV SV2002001226A patent/SV2004001226A/es not_active Application Discontinuation
- 2002-10-11 HN HN2002000254A patent/HN2002000254A/es unknown
-
2004
- 2004-02-06 ZA ZA200401002A patent/ZA200401002B/en unknown
- 2004-02-09 BG BG108569A patent/BG108569A/bg unknown
- 2004-02-13 IS IS7151A patent/IS7151A/is unknown
- 2004-02-19 HR HR20040162A patent/HRP20040162A2/xx not_active Application Discontinuation
- 2004-02-26 MA MA27550A patent/MA27062A1/fr unknown
- 2004-03-10 NO NO20041011A patent/NO20041011L/no not_active Application Discontinuation
- 2004-03-10 TN TNP2004000040A patent/TNSN04040A1/fr unknown
- 2004-03-12 EC EC2004005018A patent/ECSP045018A/es unknown
-
2005
- 2005-06-13 US US11/152,741 patent/US20050232871A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL152869A0 (en) | Substituted triazolopyrimidines as anticancer agents | |
| EP1409619A4 (en) | COMPOSITE STRUCTURAL ELEMENTS | |
| PL368370A1 (en) | Glyphosate composition | |
| ZA200604960B (en) | Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-A]pyrimidin-6-onederivatives | |
| HK1090374A1 (en) | 6-Ä(substituted)phenylÜ triazolopyrimidines as anticancer agents | |
| EP1465988A4 (en) | Myo-inositol oxygenase | |
| IL160380A0 (en) | Inhalation compositions comprising tricyclic 5,6-dihydro-9h- pyrazolo (3,4,-c)-1,2,4-triazolo (4,3-alpha) pyridines | |
| HUP0500330A3 (en) | Heterocondensated tricyclic imidazopyridines, their use and pharmaceutical compositions containing them | |
| HK1061026A1 (en) | 3,7-Diazabicyclo 3.3.1Ü formulations as antiarhythmic compounds | |
| MXPA03008965A (es) | Uso de compuestos de imidazo [1,2-a]-piridinas sustituidas como medicamentos. | |
| PL366919A1 (en) | Aromatizing agent | |
| HK1057067A1 (en) | Plating composition | |
| IL160564A0 (en) | Interconnect circuit | |
| MXPA03008894A (es) | Uso de compuestos de imidazo[1,2-a]-piridin-3-il-amidas e imidazo [1,2-a]-piridin-3-il-aminas sustituidas como medicamentos. | |
| HK1032329A2 (en) | Modular structure | |
| AU2002334256A1 (en) | Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines and a tiotropium salt | |
| GB0118950D0 (en) | Multi-purpose inhaler | |
| GB2379596B (en) | Safety cutlery | |
| HU2242U (en) | Multi-purpose playground | |
| GB0117198D0 (en) | Anti-neoplastic viral agents | |
| GB0124008D0 (en) | Compositions for inhalation | |
| GB0116752D0 (en) | Leukocyte preparation | |
| TW386454U (en) | The fitness equipment for sit/lie dual use | |
| IL141674A0 (en) | Safe cracker game | |
| GB9914783D0 (en) | Millennium multi-purpose steps |